Buy Amneal PharmaceuticalsShort Term Trading Advice by Naranj Capital
Buy Amneal Pharmaceuticals
● Buy Range- 8.5 - 8.75
● Target- 9.1 - 9.25
● StopLoss- 8.25
● Potential Return- 5-6%
● Duration- 10-12 Trading Days
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.68 USD
−83.99 M USD
2.39 B USD
126.70 M
About Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Amneal Announces Over $270M In US Opioid Lawsuit SettlementAmneal Pharmaceuticals ( NASDAQ:AMRX ) has announced a $270 million settlement to settle claims related to its alleged contribution to the opioid crisis in the U.S. The agreement, payable over a decade, aims to address a substantial portion of the more than 900 opioid-related lawsuits facing the com
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AMRX is 7.78 USD — it has increased by 0.39% in the past 24 hours. Watch Amneal Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Amneal Pharmaceuticals, Inc. stocks are traded under the ticker AMRX.
AMRX stock has fallen by −1.89% compared to the previous week, the month change is a −7.16% fall, over the last year Amneal Pharmaceuticals, Inc. has showed a 45.42% increase.
We've gathered analysts' opinions on Amneal Pharmaceuticals, Inc. future price: according to them, AMRX price has a max estimate of 12.00 USD and a min estimate of 9.00 USD. Watch AMRX chart and read a more detailed Amneal Pharmaceuticals, Inc. stock forecast: see what analysts think of Amneal Pharmaceuticals, Inc. and suggest that you do with its stocks.
AMRX reached its all-time high on Apr 9, 2015 with the price of 52.10 USD, and its all-time low was 0.81 USD and was reached on Oct 22, 1998. View more price dynamics on AMRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AMRX stock is 3.83% volatile and has beta coefficient of 0.94. Track Amneal Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Amneal Pharmaceuticals, Inc. there?
Today Amneal Pharmaceuticals, Inc. has the market capitalization of 2.41 B, it has decreased by −0.37% over the last week.
Yes, you can track Amneal Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Amneal Pharmaceuticals, Inc. is going to release the next earnings report on Feb 27, 2025. Keep track of upcoming events with our Earnings Calendar.
AMRX earnings for the last quarter are 0.16 USD per share, whereas the estimation was 0.13 USD resulting in a 19.04% surprise. The estimated earnings for the next quarter are 0.15 USD per share. See more details about Amneal Pharmaceuticals, Inc. earnings.
Amneal Pharmaceuticals, Inc. revenue for the last quarter amounts to 702.47 M USD, despite the estimated figure of 693.78 M USD. In the next quarter, revenue is expected to reach 700.83 M USD.
AMRX net income for the last quarter is −156.00 K USD, while the quarter before that showed 5.99 M USD of net income which accounts for −102.60% change. Track more Amneal Pharmaceuticals, Inc. financial stats to get the full picture.
No, AMRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 7.85 K employees. See our rating of the largest employees — is Amneal Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Amneal Pharmaceuticals, Inc. EBITDA is 571.20 M USD, and current EBITDA margin is 20.57%. See more stats in Amneal Pharmaceuticals, Inc. financial statements.
Like other stocks, AMRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Amneal Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Amneal Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Amneal Pharmaceuticals, Inc. stock shows the buy signal. See more of Amneal Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.